Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Helmut Albrecht, MD, MS, FFPM

President at H2A Associates, LLC


For the last 8 years, Dr. Albrecht has been running H2A Associates, LLC, a consulting firm for innovation & product development strategy in the OTC space (incl. Rx-to-OTC Switch), technology & opportunity assessments and product claims support, serving the pharmaceutical industry for Rx and OTC products.   Dr. Albrecht also serves as Chief Scientific Officer at Alitair Pharmaceuticals, an early-stage development company, focused on innovative formulation technology with a focus on Rx respiratory treatments and certain orphan drugs.

Prior to these endeavors, Helmut filled the roles of Sr. VP for R&D at Adams Respiratory Therapeutics and VP in US & global leadership roles in R&D at Novartis Consumer Health.  Earlier in his career he held key positions in the areas of clinical development and pharmaceutical medicine with focus on prescription drugs, the Rx & OTC drug development space and the support of OTC medicines and dietary supplement products at SmithKline Beecham, Procter & Gamble, and Altana Pharma in Germany and North America.

Helmut has an MD degree from the Universities of Heidelberg and Hamburg, a Master of Science in Management & Policy (SUNY at SB), and other qualifications in HC and Pharmaceutical Medicine.  He is a fellow and former board member of the Faculty of Pharmaceutical Medicine (RCP) in the UK.

Dr. Albrecht has an adjunct faculty appointment at Florida International University (FIU) as Associate Professor, Dept. of Cellular Biology & Pharmacology, Herbert Wertheim College of Medicine, and he is a former Industry Liaison member of FDA’s Gastrointestinal Drugs Advisory Committee (GIDAC).

Agenda Sessions